Skip to main content
Till KTH:s startsida Till KTH:s startsida

Publications by Amelie Eriksson Karlström

Peer reviewed

Articles

[3]
M. Banijamali et al., "Characterizing single extracellular vesicles by droplet barcode sequencing for protein analysis," Journal of Extracellular Vesicles, vol. 11, no. 11, 2022.
[4]
J. Caers et al., "Radiotheranostic Agents in Hematological Malignancies," Frontiers in Immunology, vol. 13, 2022.
[8]
S. S. Sahu et al., "Exploiting Electrostatic Interaction for Highly Sensitive Detection of Tumor-Derived Extracellular Vesicles by an Electrokinetic Sensor," ACS Applied Materials and Interfaces, vol. 13, no. 36, pp. 42513-42521, 2021.
[11]
S. S. Sahu et al., "Influence of molecular size and zeta potential in electrokinetic biosensing," Biosensors & bioelectronics, vol. 152, 2020.
[12]
A. Myrhammar, D. Rosik and A. Eriksson Karlström, "Photocontrolled Reversible Binding between the Protein A-Derived Z Domain and Immunoglobulin G," Bioconjugate chemistry, vol. 31, no. 3, pp. 622-630, 2020.
[14]
C. Stiller et al., "Fast and Efficient Fc-Specific Photoaffinity Labeling To Produce Antibody-DNA Conjugates," Bioconjugate chemistry, vol. 30, no. 11, pp. 2790-2798, 2019.
[15]
S. Cavallaro et al., "Label-Free Surface Protein Profiling of Extracellular Vesicles by an Electrokinetic Sensor," ACS Sensors, vol. 4, no. 5, pp. 1399-1408, 2019.
[18]
V. Tolmachev et al., "Molecular design of radiocopper-labelled Affibody molecules," Scientific Reports, vol. 8, 2018.
[20]
J. Horak et al., "Recombinant Spider Silk as Mediator for One-Step, Chemical-Free Surface Biofunctionalization," Advanced Functional Materials, vol. 28, no. 21, 2018.
[21]
S. Ståhl et al., "Affibody Molecules in Biotechnological and Medical Applications," Trends in Biotechnology, vol. 35, no. 8, pp. 691-712, 2017.
[22]
V. Tolmachev et al., "Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with Cu-64 Using NOTA and NODAGA," Contrast Media & Molecular Imaging, pp. 1-12, 2017.
[24]
H. Honarvar et al., "Evaluation of the first Sc-44-labeled Affibody molecule for imaging of HER2-expressing tumors," Nuclear Medicine and Biology, vol. 45, pp. 15-21, 2017.
[25]
A. Nilsson, J. Lindgren and A. Eriksson Karlström, "Intramolecular Thioether Crosslinking to Increase the Proteolytic Stability of Affibody Molecules," ChemBioChem (Print), vol. 18, no. 20, pp. 2056-2062, 2017.
[26]
M. Altai et al., "Comparative evaluation of Lu-177-HP2 and In-111-HP2, secondary agents for affibody-based PNA-mediated radionuclide pretargeting," European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, pp. S237-S237, 2016.
[27]
H. Honarvar et al., "Development and application of first Sc-44-labeled Affibody molecule," European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, pp. S177-S177, 2016.
[28]
A. Dev et al., "Electrokinetic effect for molecular recognition : A label-free approach for real-time biosensing," Biosensors & bioelectronics, vol. 82, pp. 55-63, 2016.
[29]
[30]
M. Altai et al., "Feasibility of Affibody-Based Bioorthogonal Chemistry Mediated Radionuclide Pretargeting," Journal of Nuclear Medicine, vol. 57, no. 3, pp. 431-436, 2016.
[33]
M. Altai et al., "Affibody-based bioorthogonal chemistry-mediated radionuclide pretargeting : proof-of-principle.," European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, pp. S246-S246, 2015.
[34]
K. Westerlund et al., "Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting," Bioconjugate chemistry, vol. 26, no. 8, pp. 1724-1736, 2015.
[35]
R. Afrasiabi et al., "Effect of microwave-assisted silanization on sensing properties of silicon nanoribbon FETs," Sensors and actuators. B, Chemical, vol. 209, pp. 586-595, 2015.
[36]
A. Perols, M. Arcos Famme and A. Eriksson Karlström, "Site-specific antibody labeling by covalent photoconjugation of Z domains functionalized for alkyne-azide cycloaddition reactions," ChemBioChem (Print), vol. 16, no. 17, pp. 2522-2529, 2015.
[37]
J. Lindgren et al., "A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life," Biopolymers, vol. 102, no. 3, pp. 252-259, 2014.
[41]
A. Perols and A. Eriksson Karlström, "Site-Specific Photoconjugation of Antibodies Using Chemically Synthesized IgG-Binding Domains," Bioconjugate chemistry, vol. 25, no. 3, pp. 481-488, 2014.
[43]
H. Honarvar et al., "Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging," Nuclear Medicine and Biology, vol. 40, no. 3, pp. 378-386, 2013.
[46]
N. Jokilaakso et al., "Ultra-localized single cell electroporation using silicon nanowires," Lab on a Chip, vol. 13, no. 3, pp. 336-339, 2013.
[47]
J. Lindgren et al., "A Native Chemical Ligation Approach for Combinatorial Assembly of Affibody Molecules," ChemBioChem (Print), vol. 13, no. 7, pp. 1024-1031, 2012.
[48]
M. Altai et al., "Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA.," European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, pp. S299-S299, 2012.
[50]
D. Rosik et al., "Direct comparison of In-111-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging," European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 4, pp. 693-702, 2012.
[53]
P. Järver, C. Mikaelsson and A. Karlstrom Eriksson, "Chemical synthesis and evaluation of a backbone-cyclized minimized 2-helix Z-domain," Journal of Peptide Science, vol. 17, no. 6, pp. 463-469, 2011.
[54]
A. Konrad, A. Eriksson Karlström and S. Hober, "Covalent Immunoglobulin Labeling through a Photoactivable Synthetic Z Domain," Bioconjugate chemistry, vol. 22, no. 12, pp. 2395-2403, 2011.
[55]
S. Chen et al., "Current Instability for Silicon Nanowire Field-Effect Sensors Operating in Electrolyte with Platinum Gate Electrodes," Electrochemical and solid-state letters, vol. 14, no. 7, pp. J34-J37, 2011.
[56]
V. Tolmachev et al., "Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules," Bioconjugate chemistry, vol. 22, no. 5, pp. 894-902, 2011.
[57]
S. Chen et al., "A two-terminal silicon nanoribbon field-effect pH sensor," Applied Physics Letters, vol. 97, no. 26, pp. 264102, 2010.
[59]
A. Orlova et al., "Re-186-maSGS-Z(HER2:342), a potential Affibody conjugate for systemic therapy of HER2-expressing tumours," European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 260-269, 2010.
[60]
T. Ekblad et al., "Positioning of Tc-99m-chelators influences radiolabeling, stability and biodistribution of Affibody molecules," Bioorganic & Medicinal Chemistry Letters, vol. 19, no. 14, pp. 3912-3914, 2009.
[61]
T. Ekblad et al., "Synthesis and chemoselective intramolecular crosslinking of a HER2-binding Affibody," Biopolymers, vol. 92, no. 2, pp. 116-123, 2009.
[62]
T. Ekblad et al., "Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake," European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 12, pp. 2245-2255, 2008.
[64]
M. G. Bjorklund et al., "Microarray analysis using disiloxyl 70mer oligonucleotides," Nucleic Acids Research, vol. 36, no. 4, pp. 1334-1342, 2008.
[65]
N. Elfström, A. Eriksson Karlström and J. Linnros, "Silicon Nanoribbons for Electrical Detection of Biomolecules," Nano letters (Print), vol. 8, no. 3, pp. 945-949, 2008.
[66]
T. Engfeldt et al., "99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule," European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 11, pp. 1843-1853, 2007.
[67]
[68]
B. Renberg et al., "Affibody molecules in protein capture microarrays : Evaluation of multidomain ligands and different detection formats," Journal of Proteome Research, vol. 6, no. 1, pp. 171-179, 2007.
[69]
T. Engfeldt et al., "Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence," European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 5, pp. 722-733, 2007.
[70]
[71]
A. Orlova et al., "Pre-clinical evaluation of -benzyl-DOTA-ZHER2 : 3429 a potential agent for imaging of HER2 expression in malignant tumors," International Journal of Molecular Medicine, vol. 20, no. 3, pp. 397-404, 2007.
[72]
N. Elfström et al., "Surface Charge Sensitivity of Silicon Nanowires : Size Dependence," Nano letters (Print), vol. 7, no. 9, pp. 2608-2612, 2007.
[75]
B. Renberg et al., "Fluorescence resonance energy transfer-based detection of analytes using antiidiotypic affinity protein pairs," Analytical Biochemistry, vol. 334, no. 1, pp. 72-80, 2004.

Conference papers

[76]
J. Horak et al., "Recombinant spider silk as mediator for one-step, chemical-free surface biofunctionalization.," in Biosensors 2018, June 2018, Miami, Florida, USA., 2018.

Chapters in books

[77]
M. Altai et al., "Preparation of Conjugates for Affibody-Based PNA-Mediated Pretargeting," in Methods in Molecular Biology, : Humana Press Inc., 2020, pp. 283-304.

Non-peer reviewed

Articles

[78]
M. Oroujeni et al., "Combined treatment of mice bearing HER2-expressing xenografts by trastuzumab and Affibody-mediated PNA-based pretargeting improves their survival," European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. SUPPL 1, pp. S158-S158, 2021.
[79]
M. Oroujeni et al., "Comparative evaluation of novel Lu-177-labeled PNA conjugates for affibody mediated PNA-based pretargeting," European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. SUPPL 1, pp. S344-S344, 2020.
[80]
A. Abouzayed et al., "Conjugation of GRPR-targeting antagonist RM26 to albumin-binding domain extends antagonist's blood circulation and residence in tumours," European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. SUPPL 1, pp. S652-S652, 2020.
[81]
M. Altai et al., "Design and evaluation oflactosaminated cetuximabas a clearing agent for antibody-based PNA-mediated pretargeting," European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. SUPPL 1, pp. S343-S344, 2020.
[82]
M. Altai et al., "A novel method for conjugation of PNA to antibodies for radionuclide based pretargeting : proof of principal," European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, pp. S648-S648, 2018.
[83]
A. Vorobyeva et al., "Development of a PET Imaging Approach for Selection of Patients for Affibody-Based PNA-Mediated Pretargeted Radionuclide Therapy," European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, pp. S104-S104, 2018.
[84]
V. Tolmachev et al., "Evaluation of NOTA and NODAGA for labelling of affibody molecules with radiocopper," Journal of labelled compounds & radiopharmaceuticals, vol. 60, pp. S230-S230, 2017.
[85]
A. Vorobyeva et al., "Feasibility of Z Domain-Mediated Conjugation of PNA to Antibodies for Radionuclide Pretargeting," European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S559-S560, 2017.
[86]
V. Tolmachev et al., "Optimal molecular design of radiocopper-labelled affibody molecules," European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S549-S549, 2017.
[87]
M. Altai et al., "Pretargeted radionuclide therapy of HER2-expressing SKOV-3 human xenografts using an Affibody molecule-based PNA-mediated pretargeting," European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S142-S142, 2017.
[88]
J. Lindgren and A. Eriksson Karlström, "Intramolecular thioether crosslinking of therapeutic proteins to increase proteolytic stability," ChemBioChem (Print), vol. 15, no. 14, pp. 2132-2138, 2014.
[90]
A. Perols and A. Eriksson Karlström, "Chemical Synthesis of Fluorescent-Labeled Affibody Molecules for Use in Cancer Diagnostics," Journal of Peptide Science, vol. 16, pp. 77-77, 2010.
[92]
P. J. Järver et al., "Synthesis and Biophysical Characterization of a Backbone-Cyclized Minimized Z Domain," Journal of Peptide Science, vol. 16, pp. 62-62, 2010.

Patents

Patents

[100]
J. Caers et al., "Anti-Cd38 Single-Domain Antibodies in Disease Monitoring and Treatment," US 2023/0190968 A1 (2023-06-22), 2023.
Latest sync with DiVA:
2024-06-21 00:01:15